Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study
- DOI
- 10.1038/s41397-025-00380-3
- Published
- 2025-07-16
- Container
- The Pharmacogenomics Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41397-025-00380-3,
title = {Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study},
author = {Tanuma Mistry and Sanghamitra Sengupta and R. Suresh Kumar and Nisha Thakur and Partha Nath and Neyaz Alam and Vilas D. Nasare},
year = {2025},
journal = {The Pharmacogenomics Journal},
doi = {10.1038/s41397-025-00380-3},
url = {https://doi.org/10.1038/s41397-025-00380-3}
}RIS
TY - JOUR TI - Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study AU - Tanuma Mistry AU - Sanghamitra Sengupta AU - R. Suresh Kumar AU - Nisha Thakur AU - Partha Nath AU - Neyaz Alam AU - Vilas D. Nasare PY - 2025 JO - The Pharmacogenomics Journal DO - 10.1038/s41397-025-00380-3 UR - https://doi.org/10.1038/s41397-025-00380-3 ER -
APA
Mistry, T., Sengupta, S., Kumar, R. S., Thakur, N., Nath, P., Alam, N., & Nasare, V. D. (2025). Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study. The Pharmacogenomics Journal. https://doi.org/10.1038/s41397-025-00380-3
Source records
- crossref · retrieved 2026-09-25T12:53:39.900Z